◀ Back to GRB2
GRB2 — MET
Pathways - manually collected, often from reviews:
-
KEGG Pathways in cancer:
MET
→
GRB2
(protein-protein, activation)
-
KEGG Renal cell carcinoma:
MET
→
GRB2
(protein-protein, activation)
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
HGF(dimer)/MET(dimer)/GRB2/GAB1 complex (MET-GRB2-GAB1-HGF)
→
SHP2 (PTPN11)
(modification, collaborate)
Schaeper et al., J Cell Biol 2000, Maroun et al., Mol Cell Biol 2000
Evidence: mutant phenotype
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
HGF(dimer)/MET(dimer)/GRB2/GAB1 complex (MET-GRB2-GAB1-HGF)
→
HGF(dimer)/MET(dimer)/GRB2/GAB1/SHP2 complex (MET-GRB2-GAB1-PTPN11-HGF)
(modification, collaborate)
Schaeper et al., J Cell Biol 2000, Maroun et al., Mol Cell Biol 2000
Evidence: mutant phenotype
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
SHP2 (PTPN11)
→
HGF(dimer)/MET(dimer)/GRB2/GAB1/SHP2 complex (MET-GRB2-GAB1-PTPN11-HGF)
(modification, collaborate)
Schaeper et al., J Cell Biol 2000, Maroun et al., Mol Cell Biol 2000
Evidence: mutant phenotype
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
HGF(dimer)/MET(dimer)/GRB2/GAB1 complex (MET-GRB2-GAB1-HGF)
→
HGF(dimer)/MET(dimer) complex (MET-HGF)
(modification, collaborate)
Schaeper et al., J Cell Biol 2000, Schaeper et al., Proc Natl Acad Sci U S A 2007, Nguyen et al., J Biol Chem 1997*
Evidence: assay, physical interaction
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
HGF(dimer)/MET(dimer)/GRB2/GAB1 complex (MET-GRB2-GAB1-HGF)
→
GRB2/GAB1 complex (GRB2-GAB1)
(modification, collaborate)
Schaeper et al., J Cell Biol 2000, Schaeper et al., Proc Natl Acad Sci U S A 2007, Nguyen et al., J Biol Chem 1997*
Evidence: assay, physical interaction
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
HGF(dimer)/MET(dimer) complex (MET-HGF)
→
GRB2/GAB1 complex (GRB2-GAB1)
(modification, collaborate)
Schaeper et al., J Cell Biol 2000, Schaeper et al., Proc Natl Acad Sci U S A 2007, Nguyen et al., J Biol Chem 1997*
Evidence: assay, physical interaction
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
None
→
HGF(dimer)/MET(dimer)/GRB2/SOS1 complex (MET-GRB2-SOS1-HGF)
(modification, collaborate)
Schaeper et al., J Cell Biol 2000, Ponzetto et al., Cell 1994, Graziani et al., J Biol Chem 1993
Evidence: assay
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
HRAS/GDP complex (HRAS)
→
HGF(dimer)/MET(dimer)/GRB2/SOS1 complex (MET-GRB2-SOS1-HGF)
(modification, collaborate)
Schaeper et al., J Cell Biol 2000, Ponzetto et al., Cell 1994, Graziani et al., J Biol Chem 1993
Evidence: assay
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
Erk1-2 (MAPK3/MAPK1)
→
HGF(dimer)/MET(dimer)/GRB2/GAB1/SHP2 complex (MET-GRB2-GAB1-PTPN11-HGF)
(modification, collaborate)
Schaeper et al., J Cell Biol 2000, Maroun et al., Mol Cell Biol 2000
Evidence: mutant phenotype
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
None
→
HGF(dimer)/MET(dimer)/p52 SHC/GRB2/SOS1 complex (MET-SHC1-GRB2-SOS1-HGF)
(modification, collaborate)
Pelicci et al., Oncogene 1995
Evidence: assay
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
HRAS/GDP complex (HRAS)
→
HGF(dimer)/MET(dimer)/p52 SHC/GRB2/SOS1 complex (MET-SHC1-GRB2-SOS1-HGF)
(modification, collaborate)
Pelicci et al., Oncogene 1995
Evidence: assay
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
GRB2 (GRB2)
→
HGF(dimer)/MET(dimer) complex (MET-HGF)
(modification, collaborate)
Parachoniak et al., J Biol Chem 2009
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
GRB2 (GRB2)
→
HGF(dimer)/MET(dimer)/GRB2 complex (MET-GRB2-HGF)
(modification, collaborate)
Parachoniak et al., J Biol Chem 2009
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
HGF(dimer)/MET(dimer) complex (MET-HGF)
→
HGF(dimer)/MET(dimer)/GRB2 complex (MET-GRB2-HGF)
(modification, collaborate)
Parachoniak et al., J Biol Chem 2009
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
HGF(dimer)/MET(dimer)/p52 SHC complex (MET-SHC1-HGF)
→
GRB2/SOS1 complex (GRB2-SOS1)
(modification, collaborate)
Pelicci et al., Oncogene 1995
Evidence: physical interaction
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
HGF(dimer)/MET(dimer)/p52 SHC complex (MET-SHC1-HGF)
→
HGF(dimer)/MET(dimer)/p52 SHC/GRB2/SOS1 complex (MET-SHC1-GRB2-SOS1-HGF)
(modification, collaborate)
Pelicci et al., Oncogene 1995
Evidence: physical interaction
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
GRB2/SOS1 complex (GRB2-SOS1)
→
HGF(dimer)/MET(dimer)/p52 SHC/GRB2/SOS1 complex (MET-SHC1-GRB2-SOS1-HGF)
(modification, collaborate)
Pelicci et al., Oncogene 1995
Evidence: physical interaction
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
EPS15 (EPS15)
→
HGF(dimer)/MET(dimer)/GRB2 complex (MET-GRB2-HGF)
(modification, collaborate)
Parachoniak et al., J Biol Chem 2009
Evidence: physical interaction
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
EPS15 (EPS15)
→
HGF(dimer)/MET(dimer)/GRB2/EPS15 complex (MET-GRB2-EPS15-HGF)
(modification, collaborate)
Parachoniak et al., J Biol Chem 2009
Evidence: physical interaction
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
HGF(dimer)/MET(dimer)/GRB2 complex (MET-GRB2-HGF)
→
HGF(dimer)/MET(dimer)/GRB2/EPS15 complex (MET-GRB2-EPS15-HGF)
(modification, collaborate)
Parachoniak et al., J Biol Chem 2009
Evidence: physical interaction
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
HGF(dimer)/MET(dimer)/GRB2/SOS1 complex (MET-GRB2-SOS1-HGF)
→
HGF(dimer)/MET(dimer) complex (MET-HGF)
(modification, collaborate)
Higuchi et al., Mol Cell Biol 2004, Ponzetto et al., Cell 1994
Evidence: assay, physical interaction
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
HGF(dimer)/MET(dimer)/GRB2/SOS1 complex (MET-GRB2-SOS1-HGF)
→
GRB2/SOS1 complex (GRB2-SOS1)
(modification, collaborate)
Higuchi et al., Mol Cell Biol 2004, Ponzetto et al., Cell 1994
Evidence: assay, physical interaction
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
HGF(dimer)/MET(dimer) complex (MET-HGF)
→
GRB2/SOS1 complex (GRB2-SOS1)
(modification, collaborate)
Higuchi et al., Mol Cell Biol 2004, Ponzetto et al., Cell 1994
Evidence: assay, physical interaction
-
NCI Pathway Database Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met):
GRB2/SOS1 complex (GRB2-SOS1)
→
MET/MUC20 complex (MET-MUC20)
(modification, collaborate)
Higuchi et al., Mol Cell Biol 2004, Ponzetto et al., Cell 1994
Evidence: assay, physical interaction
-
WikiPathways Focal Adhesion-PI3K-Akt-mTOR-signaling pathway:
FGFR2/KDR/INSR/FGFR3/IGF1R/KIT/FGFR1/EPHA2/EGFR/CSF1R/FGFR4/FLT1/FLT4/NGFR/MET/PDGFRA/PDGFRB/TEK
→
GRB2
(activation)
-
WikiPathways Signaling Pathways in Glioblastoma:
IGF1R/ERBB3/FGFR1/PDGFRA/PDGFRB/ERBB2/EGFR/FGFR2/MET
→
GRB2
(mim-stimulation)
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
-
IRef Biogrid Interaction:
MET
—
GRB2
(physical association, affinity chromatography technology)
Goldoni et al., J Cell Biol 2009*
-
IRef Biogrid Interaction:
MET
—
GRB2
(direct interaction, pull down)
Hill et al., J Exp Ther Oncol 2010*
-
IRef Biogrid Interaction:
MET
—
GRB2
(direct interaction, pull down)
Ponzetto et al., J Biol Chem 1996*
-
IRef Biogrid Interaction:
MET
—
GRB2
(physical association, affinity chromatography technology)
Liang et al., Invest Ophthalmol Vis Sci 1998*
-
IRef Hprd Interaction:
Complex of GRB2-GAB1-MET-MET-GAB1-GRB2-GAB1-MET-GRB2
(in vivo)
Schaeper et al., J Cell Biol 2000
-
IRef Hprd Interaction:
MET
—
GRB2
(two hybrid)
Crostella et al., Oncogene 2001*, Schaaf et al., FASEB J 2005*, Songyang et al., Mol Cell Biol 1994*, Ponzetto et al., J Biol Chem 1996*, Liang et al., Invest Ophthalmol Vis Sci 1998*
-
IRef Hprd Interaction:
MET
—
GRB2
(in vitro)
Crostella et al., Oncogene 2001*, Schaaf et al., FASEB J 2005*, Songyang et al., Mol Cell Biol 1994*, Ponzetto et al., J Biol Chem 1996*, Liang et al., Invest Ophthalmol Vis Sci 1998*
-
IRef Hprd Interaction:
MET
—
GRB2
(in vivo)
Crostella et al., Oncogene 2001*, Schaaf et al., FASEB J 2005*, Songyang et al., Mol Cell Biol 1994*, Ponzetto et al., J Biol Chem 1996*, Liang et al., Invest Ophthalmol Vis Sci 1998*
-
IRef Ophid Interaction:
GRB2
—
MET
(aggregation, interologs mapping)
Brown et al., Bioinformatics 2005
Text-mined interactions from Literome
Bardelli et al., Oncogene 1999
(Cell Transformation, Neoplastic...) :
Conversely,
MetP13K/Grb2 induced motility, transformation, invasion and metastasis as efficiently as wild type
Met
Petrelli et al., Nature 2002
:
Cbl, in turn, binds and ubiquitinates activated
HGF receptor , and by recruiting the
endophilin-CIN85 complex , it
regulates receptor internalization
Seiden-Long et al., Carcinogenesis 2008
(Colorectal Neoplasms...) :
This suggests that direct
Grb2/Shc binding does not
contribute to the tumor progression activity of
Met receptor